Sanofi downplays impact of GSK's head start in flu season
Sanofi points to the differentiation of its high-dose influenza vaccine to argue it will prosper this flu season, despite coming to market after GSK.
Archives for November 6, 2019
Pfizer pushes for end to 'rebate trap’ to boost biosimilars
Pfizer’s CEO frames the rebates offered by manufacturers of originator biologics as the fundamental barrier to uptake of biosimilars in the US.
Samsung takes on clinical manufacturing of Ichnos’ mAb candidate
Samsung continues an agreement formerly signed with Glenmark to manufacture Ichnos’ mAb treatment candidate for atopic dermatitis, as the product enters Phase III clinical trials.